244 related articles for article (PubMed ID: 16625121)
1. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas.
Wang J; Oldner A; Winskog C; Edston E; Walther SM
Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121
[TBL] [Abstract][Full Text] [Related]
2. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment.
Wang J; Zhang L; Walther SM
Intensive Care Med; 2002 Mar; 28(3):352-7. PubMed ID: 11904667
[TBL] [Abstract][Full Text] [Related]
3. Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs.
Wang J; Winskog C; Edston E; Walther SM
Acta Anaesthesiol Scand; 2005 Feb; 49(2):183-90. PubMed ID: 15715619
[TBL] [Abstract][Full Text] [Related]
4. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
5. Effects of a dual endothelin-1 receptor antagonist on airway obstruction and acute lung injury in sheep following smoke inhalation and burn injury.
Cox RA; Enkhabaatar P; Burke AS; Katahira J; Shimoda K; Chandra A; Traber LD; Herndon DN; Hawkins HK; Traber DL
Clin Sci (Lond); 2005 Mar; 108(3):265-72. PubMed ID: 15554871
[TBL] [Abstract][Full Text] [Related]
6. Endothelin antagonists: new bullets against lung injury?
Leeman M
Crit Care; 2005 Jun; 9(3):245-6. PubMed ID: 15987411
[TBL] [Abstract][Full Text] [Related]
7. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
8. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
Persson BP; Rossi P; Weitzberg E; Oldner A
Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
[TBL] [Abstract][Full Text] [Related]
9. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
[TBL] [Abstract][Full Text] [Related]
10. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
Geiger R; Pajk W; Neu N; Maier S; Kleinsasser A; Fratz S; Navarro-Psiha S; Fischer V; Treml B; Loeckinger A
Pediatr Res; 2006 Jan; 59(1):147-50. PubMed ID: 16327003
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonism by tezosentan attenuates lung injury induced by aortic ischemia-reperfusion.
Kiriş I; Narin C; Gülmen S; Yilmaz N; Sütçü R; Kapucuoğlu N
Ann Vasc Surg; 2009; 23(3):382-91. PubMed ID: 19135850
[TBL] [Abstract][Full Text] [Related]
12. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
[TBL] [Abstract][Full Text] [Related]
13. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock.
Andersson A; Fenhammar J; Frithiof R; Weitzberg E; Sollevi A; Hjelmqvist H
J Surg Res; 2008 Sep; 149(1):138-47. PubMed ID: 18639249
[TBL] [Abstract][Full Text] [Related]
14. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
[TBL] [Abstract][Full Text] [Related]
15. Chest wall disruption with and without acute lung injury: effects of continuous positive airway pressure therapy on ventilation and perfusion relationships.
Schweiger JW; Downs JB; Smith RA
Crit Care Med; 2003 Sep; 31(9):2364-70. PubMed ID: 14501968
[TBL] [Abstract][Full Text] [Related]
16. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
17. Effect of the endothelin receptor antagonist tezosentan on alpha-naphthylthiourea-induced lung injury in rats.
Atalay F; Yurdakan G; Yilmaz-Sipahi E
Kaohsiung J Med Sci; 2012 Feb; 28(2):72-8. PubMed ID: 22313533
[TBL] [Abstract][Full Text] [Related]
18. Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).
O'Connor CM; Gattis WA; Adams KF; Shah MR; Frey A; Gheorghiade M;
Am Heart J; 2003 Feb; 145(2 Suppl):S58-9. PubMed ID: 12594454
[No Abstract] [Full Text] [Related]
19. Cardiopulmonary bypass is associated with altered vascular reactivity of isolated pulmonary artery in a porcine model: therapeutic potential of inhaled tezosentan.
Mommerot A; Denault AY; Dupuis J; Carrier M; Perrault LP
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):698-708. PubMed ID: 24917060
[TBL] [Abstract][Full Text] [Related]
20. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
Teerlink JR; McMurray JJ; Bourge RC; Cleland JG; Cotter G; Jondeau G; Krum H; Metra M; O'Connor CM; Parker JD; Torre-Amione G; Van Veldhuisen DJ; Frey A; Rainisio M; Kobrin I;
Am Heart J; 2005 Jul; 150(1):46-53. PubMed ID: 16084150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
